Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 60Head and Neck Neoplasms 22Squamous Cell Carcinoma of Head and Neck 21Lung Neoplasms 20Carcinoma, Non-Small-Cell Lung 20Colorectal Neoplasms 19Melanoma 17Colonic Neoplasms 16Rectal Neoplasms 15Carcinoma, Renal Cell 13Pancreatic Neoplasms 12Lymphoma 12Prostatic Neoplasms 11Ovarian Neoplasms 11Lymphoma, Follicular 11Carcinoma, Ovarian Epithelial 11Kidney Neoplasms 9Breast Neoplasms, Male 9Salivary Gland Neoplasms 8Lymphoma, Large B-Cell, Diffuse 8Central Nervous System Neoplasms 8Sarcoma 7Liver Neoplasms 7Esophageal Neoplasms 7Uterine Cervical Neoplasms 6Urinary Bladder Neoplasms 6Unspecified Adult Solid Tumor, Protocol Specific 6Neuroblastoma 6Lymphoma, Large-Cell, Anaplastic 6Lymphoma, B-Cell, Marginal Zone 6

Interventions

Transcriptome 1Taxes 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Paclitaxel 1Microarray Analysis 1Immunohistochemistry 1Gene Expression Profiling 1Carboplatin 1Blotting, Western 1Biopsy 13-aminopyridine-2-carboxaldehyde thiosemicarbazone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endometrial Serous Adenocarcinoma × Immunohistochemistry × Clear all
NCT01344837 2024-08-14

Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer

GOG Foundation

Completed
360 enrolled
Gynecologic

Endometrial Serous Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡